Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Apr;15(4):e010795.
doi: 10.1161/CIRCEP.121.010795. Epub 2022 Mar 31.

Feasibility of a Randomized Clinical Trial of Cardiac Resynchronization Therapy With or Without an Implantable Defibrillator in Older Patients

Andrew D Althouse  1 , Sandeep Kumar Jain  2 , Alaa Shalaby  3 , Madhurmeet Singh  2 , Raul Weiss  4 , Larissa Myaskovsky  5 , Sana M Al-Khatib  6 , Samir Saba  2
Affiliations
Randomized Controlled Trial

Feasibility of a Randomized Clinical Trial of Cardiac Resynchronization Therapy With or Without an Implantable Defibrillator in Older Patients

Andrew D Althouse et al. Circ Arrhythm Electrophysiol. 2022 Apr.
No abstract available

Keywords: aged; cardiac resynchronization therapy; defibrillators; heart failure; humans.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overall design of the study with its observational prospective registry (n=60 patients) and its RCT (n=42 patients) components is shown in panel A. Panel B details the enrollment timeline for the observational registry and the RCT. Kaplan Meier curves are shown comparing the overall survival of patients enrolled in the observational registry versus the RCT (panel C) and for those in the randomized trial who received a CRT-P versus a CRT-D (panel D). UPMC = University of Pittsburgh Medical Center; OSUMC = Ohio State University Medical Center; VA PITT = Veterans Affairs hospital of Pittsburgh; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; CRT-P = cardiac resynchronization therapy pacemaker; CRT-D = cardiac resynchronization therapy defibrillator; OBS = observational registry; RCT = randomized controlled trial; HR = hazard ratio; CI = confidence interval.
See this image and copyright information in PMC

References

    1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, et al. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. J Am Coll Cardiol. 2013;61:e6–e75. - PubMed
    1. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes III NAM, Greenberg H, Hall WJ, Huang DT, et al. Reduction in Inappropriate Therapy and Mortality through ICD Programming. NEJM. 2012;367:2275–2283. - PubMed
    1. Francis J, Johnson B, Niehaus M. Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol J. 2006;6:173–181. - PMC - PubMed
    1. Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014. Heart Rhythm. 2019;16:1065–1071. - PubMed
    1. Saba S, Adelstein E, Wold N, Stein K, Jones P. Influence of patients’ age at implantation on mortality and defibrillator shocks. Europace. 2017;19:802–807. - PubMed

Publication types

Associated data